In this webinar, Emyria Managing Director - Dr Michael Winlo and UWA Professor of Medicinal Chemistry - Dr Matt Piggott, discuss Emyria's MDMA-inspired drug discovery program.

In this webinar, we will cover:

- What is MDMA?

- How MDMA is being used therapeutically today?

- What makes MDMA a promising compound to innovate from? (eg. create new, related molecules)

- What properties of MDMA we are trying to alter to create new treatments for mental health and neuroscience?

- What have been some of the promising early results?

- What can shareholders can expect over the next 6-12 months?